The present invention relates to the use of electrochemical aptamer sensors.
This section is intended to introduce the reader to various aspects of art that may be related to various aspects of the present invention, which are described and/or claimed below. This discussion is believed to be helpful in providing the reader with background information to facilitate a better understanding of various aspects of the present invention. Accordingly, it should be understood that these statements are to be read in this light, and not as admissions of prior art.
Electrochemical aptamer sensors can identify the presence and/or concentration of an analyte of interest via the use of an aptamer sequence that specifically binds to the analyte of interest. These sensors include aptamers attached to an electrode, wherein each of the aptamers has a redox active molecule (redox couple) attached thereto. The redox couple can transfer electrical charge to or from the electrode. When an analyte binds to the aptamer, the aptamer changes shape, bringing the redox couple closer to or further from, on average, the electrode. This results in a measurable change in electrical current that can be translated to a measure of concentration of the analyte. Such electrochemical aptamer sensors may include multiple (2 or 3 or more) electrodes. These aptamer sensors have been developed for (1) in vivo testing (placed in an animal) where the sample volume is quite large, and (2) in vitro testing (e.g., 96 well assays) where the sample volume is also quite large (>100s of μL).
Apart from these examples of relatively large sample volume testing, there are also testing scenarios based on blood-prick tests, single data point microneedle ISF sampling, and others, where sample volumes can be on the order of 30 μL or smaller. Such small sample volumes result in additional challenges regarding the use of electrochemical aptamer sensors that have not been resolved to date (and so, to date, electrochemical aptamer sensing has not been successfully and accurately used in small sample volume testing). First, because aptamers are affinity-based biosensors, they physically bind to the analyte of interest, which can deplete the amount of that analyte in the sample solution, resulting in a measurement error. For example, if a sample volume is 1 μL, and the aptamer sensor has enough aptamers that it absorbs the same amount of analyte that would be in 0.2 μL, then the analyte concentration in the sample volume will decrease by ˜20%, resulting in a measurement error. Second, small sample volumes require that devices including electrochemical aptamer sensor(s) also include small cavities to hold the sample volume to be tested—in order to make sure that the sample is brought to, or positioned in, a location proximal to the sensor (and thus to the aptamers) so that the sample fluid (and any target analyte therein) will actually contact/confront the electrode(s) and aptamer(s). However, as the cavity around the sensor is reduced in size in order to accomplish this, the electrical impedance between the 2 or 3 or more electrodes comprising the electrochemical aptamer sensor can begin to shift, confound, or weaken the measurement signal.
Thus, small sample volume aptamer sensing remains a new application with several unaddressed challenges that will confound, if not prohibit, use of aptamer sensing technologies at these volumes. A need still exists for devices and methods to permit small volume aptamer sensing without drawbacks such as analyte depletion or solution impedance.
Certain exemplary aspects of the invention are set forth below. It should be understood that these aspects are presented merely to provide the reader with a brief summary of certain forms the invention might take and that these aspects are not intended to limit the scope of the invention. Indeed, the invention may encompass a variety of aspects that may not be explicitly set forth below.
Many of the drawbacks and limitations stated above can be resolved by creating novel and advanced interplays of chemicals, materials, sensors, electronics, microfluidics, algorithms, computing, software, systems, and other features or designs, in a manner that affordably, effectively, conveniently, intelligently, or reliably brings sensing technology into proximity with sample fluids containing at least one analyte of interest to be measured.
Various aspects of the disclosed invention overcome the drawbacks and limitations described above by providing aptamer sensors that permit small sample volume aptamer sensing without the issues of analyte depletion or solution impedance discussed above.
In that regard, one aspect of the disclosed invention is directed to a device including at least one substrate that defines a microfluidic feature having a defined volume. At least one electrochemical aptamer sensor is carried by the substrate and in fluid communication with the defined volume of the microfluidic feature. The electrochemical aptamer sensor includes at least one electrode and at least one aptamer associated with the at least one electrode (and at least one redox couple may further be associated with the at least one aptamer). In addition to the electrochemical aptamer sensor, the defined volume is also adapted to hold a sample fluid. In this aspect of the disclosed invention, the defined volume containing the sensor is capable of also containing less than 30 μL of a sample fluid when the defined volume is filled with the sample fluid and the electrochemical aptamer sensor.
Another aspect of the disclosed invention is directed to a device similar to that described above. In this aspect, the device includes at least one substrate that defines a microfluidic feature having a defined volume. At least one electrochemical aptamer sensor is carried by the substrate and in fluid communication with the defined volume of the microfluidic feature. The electrochemical aptamer sensor includes at least one electrode and at least one aptamer associated with the at least one electrode (and at least one redox couple may further be associated with the at least one aptamer). In addition to the electrochemical aptamer sensor, the defined volume is also adapted to hold a sample fluid. In this particular aspect of the disclosed invention, the volume of the sample fluid in μL is equal to C * the surface area of the electrode in cm2 that is available for binding of at least one aptamer thereto/concentration of the target analyte in μM; and C has a value chosen from less than 4, less than 0.4, less than 0.04, and less than 0.004.
Another aspect of the disclosed invention is directed to a method that includes bringing a sample fluid (that includes, or potentially includes a target analyte) into proximity with an electrochemical aptamer sensor comprising at least one electrode and at least one aptamer associated with the at least one electrode. In an embodiment of this method, the volume of the sample fluid in μL may be equal to C * the surface area of the electrode in cm2 that is available for binding of at least one aptamer thereto/concentration of the target analyte in μM. C may have a value chosen from less than 4, less than 0.4, less than 0.04, and less than 0.004. In this, or an alternate, embodiment, the defined volume may contain less than 30 μL of a sample fluid. The method may then involve detecting and/or measuring a change in electrical current involving the at least one electrode following bringing the sample fluid into proximity with the electrochemical aptamer sensor.
The objects and advantages of the disclosed invention will be further appreciated in light of the following detailed descriptions and drawings in which:
As used herein, the term “about,” when referring to a value or to an amount of mass, weight, time, volume, pH, size, concentration or percentage is meant to encompass variations of ±20% in some embodiments, ±10% in some embodiments, ±5% in some embodiments, ±1% in some embodiments, ±0.5% in some embodiments, and ±0.1% in some embodiments from the specified amount, as such variations are appropriate to perform the disclosed method.
As used herein, the term “aptamer” means a molecule that undergoes a conformation change as an analyte binds to the molecule, and which satisfies the general operating principles of the sensing method as described herein. Such molecules are, e.g., natural or modified DNA, RNA, or XNA oligonucleotide sequences, spiegelmers, peptide aptamers, and affimers. Modifications may include substituting unnatural nucleic acid bases for natural bases within the aptamer sequence, replacing natural sequences with unnatural sequences, or other suitable modifications that improve sensor function.
The devices and methods described herein encompass the use of sensors. A sensor, as used herein, is a device that is capable of measuring the concentration of a target analyte in solution. As used herein, an “analyte” may be any inorganic or organic molecule, for example: a small molecule drug, a metabolite, a hormone, a peptide, a protein, a carbohydrate, a nucleic acid, or any other composition of matter. The target analyte may comprise a drug. The drug may be of any type, for example, including drugs for the treatment of cardiac system, the treatment of the central nervous system, that modulate the immune system, that modulate the endocrine system, an antibiotic agent, a chemotherapeutic drug, or an illicit drug. The target analyte may comprise a naturally-occurring factor, for example a hormone, metabolite, growth factor, neurotransmitter, etc. The target analyte may comprise any other species of interest, for example, species such as pathogens (including pathogen induced or derived factors), nutrients, and pollutants, etc.
One or more specific embodiments of the present invention will be described below. In an effort to provide a concise description of these embodiments, all features of an actual implementation may not be described in the specification. It should be appreciated that in the development of any such actual implementation, as in any engineering or design project, numerous implementation-specific decisions must be made to achieve the developers' specific goals, such as compliance with system-related and business-related constraints, which may vary from one implementation to another. Moreover, it should be appreciated that such a development effort might be complex and time consuming, but would nevertheless be a routine undertaking of design, fabrication, and manufacture for those of ordinary skill having the benefit of this disclosure.
Certain embodiments of the disclosed invention show sensors as simple individual elements. It is understood that many sensors require two or more electrodes, reference electrodes, or additional supporting technology or features which are not captured in the description herein. Sensors measure a characteristic of an analyte. Sensors are preferably electrical in nature, but may also include optical, chemical, mechanical, or other known biosensing mechanisms. Sensors can be in duplicate, triplicate, or more, to provide improved data and readings. Sensors may provide multiple or discrete data and/or readings. Certain embodiments of the disclosed invention show sub-components of what would be sensing devices with more sub-components needed for use of the device in various applications, which are known (e.g., a battery, antenna, adhesive), and for purposes of brevity and focus on inventive aspects, such components may not be explicitly shown in the diagrams or described in the embodiments of the disclosed invention. All ranges of parameters disclosed herein include the endpoints of the ranges.
Various aspects of the disclosed invention overcome the drawbacks and limitations described above by providing an aptamer sensor or sensors that permit small sample volume aptamer sensing without the issues of analyte depletion or solution impedance. The aptamer sensors may be aptamer sensors that permit small volume aptamer sensing without analyte depletion or solution impedance.
In that regard, one aspect of the disclosed invention is directed to a device including at least one electrochemical aptamer sensor for small sample volume sensing. A device of this aspect includes at least one substrate that defines a microfluidic feature having a defined volume. At least one electrochemical aptamer sensor is carried by the substrate and in fluid communication with the defined volume of the microfluidic feature. The electrochemical aptamer sensor includes at least one electrode and at least one aptamer associated with the at least one electrode (and at least one redox couple may further be associated with the at least one aptamer). In addition to the electrochemical aptamer sensor, the defined volume is also adapted to hold a sample fluid. In this aspect of the disclosed invention, the defined volume containing the sensor is capable of also containing less than 30 μL of a sample fluid when the defined volume is filled with the sample fluid and the electrochemical aptamer sensor.
Another aspect of the disclosed invention is directed to a device similar to that described above. In this aspect, the device includes at least one substrate that defines a microfluidic feature having a defined volume. At least one electrochemical aptamer sensor is carried by the substrate and in fluid communication with the defined volume of the microfluidic feature. The electrochemical aptamer sensor includes at least one electrode and at least one aptamer associated with the at least one electrode (and at least one redox couple may further be associated with the at least one aptamer). In addition to the electrochemical aptamer sensor, the defined volume is also adapted to hold a sample fluid. In this particular aspect of the disclosed invention, the volume of the sample fluid in μL is equal to C * the surface area of the electrode in cm2 that is available for binding of at least one aptamer thereto/concentration of the target analyte in μM; and C has a value chosen from less than 4, less than 0.4, less than 0.04, and less than 0.004.
Thus, and with reference to
To further explain certain principles of this invention, and of the devices and methods disclosed herein (such as a device shown in
Thus, the disclosed invention, in one embodiment, can be considered to involve a linear relationship between analyte concentration and fluid volume/cm2 of electrode area. As discussed in the example above:
0.83 μL=C*electrode area in cm2/5μM
where, regardless of scientific unit requirements, C is a simple proportionality constant as taught above and can be validated experimentally to be about 4.15. Thus, more generically described:
Sample fluid volume in μL=C*electrode area in cm2/concentration in μM.
And so, if electrode area decreases, fluid volume may decrease. And if the concentration to be measured decreases, sample fluid volume may be increased.
However, while 1 μM to 5 μM (in the general example discussed above) may be a viable concentration range for many drugs and analytes, it is not a viable concentration range for many native biomarkers in the body (cardiac, hormones, etc.). Consider, for example, free cortisol at ˜5 nM, or cardiac markers such as BNP at 5 pM. For these examples, the respective sample volumes (following the calculations of the example above) would need to be 830 μL, and 830,000 μL respectively. Such sample volumes are clearly beyond the reasonable limits/volumes collectable via blood pricks or ISF extraction. Even if 10% analyte depletion were permitted and therefore ˜10% additional measurement error tolerated, the resulting volumes of 83 μL and 83,000 μL are still problematic.
And so, as described above, a device in accordance with principles of the disclosed invention may be designed to have a sample volume equal to C * the surface area of the electrode in cm2 that is available for binding of at least one aptamer thereto/concentration of the target analyte in μM. C may have a value chosen from less than 4, less than 0.4, less than 0.04, and less than 0.004, where lower values for C allow for smaller sample volumes in μL, or at a fixed sample volume, will require the electrode area or aptamer density to be decreased such that less analyte depletion occurs. Generally speaking, a lower value for C enables improved device performance in terms of less sample volume required or less analyte depletion. This allows for sample testing even for many biomarkers in the body that are typically present in concentrations lower than the 1 μM to 5 μM range (e.g., free cortisol at ˜5 nM, or BNP at 5 pM).
In one embodiment, the disclosed invention is a device having at least one electrochemical aptamer sensor within a defined volume filled with less than 30 μL of a sample fluid (and in further embodiments, less than 10 μL of a sample fluid). Further, the defined volume is defined, at least in part, by at least one substrate. In another embodiment, the sample fluid has a volume in μL=C * electrode area in cm2/concentration in μM, and C is less than 4. In one embodiment, electrochemical aptamer sensor has an aptamer density on the sensor of greater than 5E9/cm2, and also includes an electrode that is less than 0.5 cm2.
C, as taught above, is valid for 5E10 aptamers/cm2. In an embodiment of the disclosed invention, the aptamer density can be reduced instead of reducing electrode area to achieve values for C that are at least one of less than 4, less than 0.4, less than 0.04, less than 0.004 where C is calculated as illustrated above. One challenge with reducing C and aptamer density is that the background current for an aptamer sensor is fixed, and eventually signal to noise ratio for the sensor signal will become problematic. Therefore, additional embodiments of the disclosed invention are also disclosed.
In that regard, assume again the case of C=4.15, which is for 5E10 aptamers/cm2, and a sample volume of 0.83 μL/cm2, and instead vary the ratio of sample volume to electrode area. In order to maintain sensor signal compared to sensor noise (background current), the aptamer density should be greater than 5E9/cm2, and for a sample volume that is less than 10 μL the electrode area should be at least one of less than 0.5, 0.05, 0.005, 0.0005 cm2. And so, one embodiment of the device is configured such that the at least one electrochemical aptamer sensor includes a plurality of aptamers on the at least one electrode at an aptamer density of >5E9/cm2, and wherein the at least one electrode has a surface area for association with the plurality of aptamers, the surface area being chosen from a surface area less than 0.5 cm2, a surface area less than 0.05 cm2, a surface area less than 0.005 cm2, and a surface area less than 0.0005 cm2.
Aptamer densities on a planar gold surface can be greater than 5E10/cm2, greater than 5E11/cm2, or even greater than 5E12/cm2, depending on the aptamer, the sample fluid, the desired signal gain, or other relevant parameters. It is understood that an electrode could also be roughened, porous, have dendrites, such that its surface area is increased. For example, porous gold electrodes can have greater than 100×higher surface area, and if aptamer on that gold was deposited at 5E10/cm2, effectively for purposes of the present invention where analyte depletion is a concern, the effective aptamer density in the calculations made herein would be 5E10/cm2*100=5E12/cm2 if the gold surface area was 100× greater than a planar gold electrode. Rough or porous electrode surface areas generally can be up to 1000× higher than a planar electrode, and therefore an aptamer density on a planar electrode of greater than 5E12/cm2 can be interpreted in the present invention having an effective aptamer density of greater than 5E15/cm2 with respect to causing analyte depletion. Therefore, the range of aptamer densities in the present invention generally include, but are not necessarily limited to a density of 5E9/cm2 on the low end for planar electrodes to an effective density of 5E15/cm2 on the high end for rough or porous electrodes, which herein for simplicity will just be referred to as an aptamer density range of 5E9/cm2 to 5E15/cm2. These higher densities easily then teach how the lower end of electrode area of 0.0005 cm2 may be required, for example with an electrode that is ˜71 μm×71 μm in area.
However, with further reference to
Therefore,
While
With further reference to
This mitigates analyte diffusion and depletion limitations as discussed above, because the volume near the sensor is as large as possible. Taught in another manner, in one embodiment of the device, (1) the defined volume of the microfluidic feature has a total volume (Vd), (2) a subset (Vs) of that volume is adjacent to the electrode, and (3) Vs is definable geometrically by being the volume that is equidistant from the electrode. In various embodiments, Vs may therefore have a value that is chosen from greater than 2% of Vd, greater than 5% of Vd, greater than 10% of Vd, greater than 20% of Vd, and greater than 50% of Vd.
With further reference to
With further reference to
With reference to
The embodiments discussed thus far deal with aptamers that are bound to a surface such as electrode. In alternate embodiments of devices and methods of the disclosed invention, aptamers could also be in solution. For example, at the inlet of a test strip a first type of aptamer tagged with a redox couple such as methylene blue could dissolve into solution, and the electrochemical aptamer sensor 120, 220 could contain a second type of aptamer that binds with the first type of aptamer depending on binding with the analyte with the first or second set of aptamers. Such two aptamer constructs are known by those skilled in the art of aptamers.
Additionally, a single type of aptamer could be released into solution near the inlet of a device or at other locations of the device, and the aptamer have a redox tag that becomes less or more available to an electrode 122 or 222a depending on analyte binding to the aptamer (for example, the analyte binding could disrupt an aptamer folding pattern that allows the redox couple to become more external to the aptamer because with the aptamer folding pattern much of the aptamer surrounded the redox couple). Aptamers could also be optical in nature, and if used in a test-strip format dissolved into solution inside a test strip and measured similar to how molecular-beacon aptamers are tested. The point of these examples is not the examples themselves but rather that the present invention also applies to aptamers in solution and the effects on analyte depletion. Such calculations are simpler, because to avoid analyte depletion, the aptamer concentration could be much less than the analyte depletion, and ideally the aptamer concentration in solution would be less than at least one of 50%, 20%, 10%, 5%, 2%, 1% of the analyte concentration in solution. For example, for a drug analyte such as vancomycin at a concentration of 10 μM the aptamer concentration in solution could be 1 μM such that the sensor is at least 90% accurate in its measurement of the drug analyte concentration.
The devices of the various embodiments of the disclosed invention may take different forms—for example, such devices may include a blood test strip and a microneedle test device.
With reference to
Another aspect of the disclosed invention is directed to a method that includes bringing a sample fluid (that includes, or potentially includes a target analyte) into proximity with an electrochemical aptamer sensor comprising at least one electrode and at least one aptamer associated with the at least one electrode. In an embodiment of this method, the volume of the sample fluid in μL may be equal to C * the surface area of the electrode in cm2 that is available for binding of at least one aptamer thereto/concentration of the target analyte in μM. C may have a value chosen from less than 4, less than 0.4, less than 0.04, and less than 0.004.
Further, in this method, at least one redox couple may be associated with the at least one aptamer, and the method further includes the step of measuring an initial electrical current between the at least one electrode and the at least one redox couple. Following bringing the sample fluid into proximity with the electrochemical aptamer sensor, then, the method may include detecting and/or measuring a change from the initial electrical current between the at least one electrode and the at least one redox couple. Detecting this change can indicate the presence of target analyte in the sample fluid. And measuring this change can be used to determine the concentration of target analyte in the sample fluid.
In certain embodiments, bringing the sample fluid into proximity with the electrochemical aptamer sensor may further include bringing less than 30 μL of sample fluid into proximity with the electrochemical aptamer sensor.
Further, in certain embodiments, bringing the sample fluid into proximity with the electrochemical aptamer sensor may include delivering the fluid sample into a defined volume of a microfluidic feature of a device, wherein the defined volume of the microfluidic feature is in fluid communication with the electrochemical aptamer sensor.
There are different embodiments of devices that can be used in accordance with principles of the disclosed invention, consistent with the method aspect of the invention described above. For example, bringing the sample fluid into proximity with the electrochemical aptamer sensor may be achieved by bringing at least one microneedle associated with the device into contact with the epidermis, dermis, hypodermis, blood vessel, or capillary of a subject. The at least one microneedle may then include a lumen in fluid communication with the interior space to deliver sample fluid from the subject (e.g., from the epidermis, dermis, hypodermis, blood vessel, or capillary) to the defined volume of the interior space.
Alternatively, bringing the sample fluid into proximity with the electrochemical aptamer sensor may be achieved by placing a blood sample onto a material of the device in order for at least a portion of the blood sample to be transported into the defined volume of the interior space.
Although not described in detail herein, other steps which are readily interpreted from or incorporated along with the disclosed embodiments shall be included as part of the invention. The embodiments that have been described herein provide specific examples to portray inventive elements, but will not necessarily cover all possible embodiments commonly known to those skilled in the art.
This application claims the benefit of the filing date of U.S. Provisional Application No. 63/083,031 filed Sep. 24, 2020, claims the benefit of the filing date of U.S. Provisional Application No. 63/150,717 filed Feb. 18, 2021, and claims the benefit of the filing date of U.S. Provisional Application No. 63/197,674 filed Jun. 7, 2021, the disclosures of all of which are incorporated by reference herein in their entireties.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2021/051931 | 9/24/2021 | WO |
Number | Date | Country | |
---|---|---|---|
63197674 | Jun 2021 | US | |
63150717 | Feb 2021 | US | |
63083031 | Sep 2020 | US |